RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • 원저(原著) : 간 질환자의 C형 간염항체 및 B형 간염항원 양성율

        조창호 ( Chaog-ho Cho ),김창일 ( Chang-it Kim ),박경희 ( Kyung-hee Park ) 대한임상병리사협회 1994 임상수혈검사학회 발표자료집 Vol.1 No.1

        In order to elucidate the prevalence of anti-HCV and HBsAg in liver disease patients, we examined anti-HCV and HBV markers in 359 samples from blood donors and 563 samples from liver disease patients using ELA method. The prevalence of anti-HCV in liver disease patients(12.1 %) was significantly higher than that(1.l %) of blood donors(P<0.05). Among blood donors the prevalence of anti-HCV in male(1.5 %) was not significantly higher than that(0.0%) in female. but in liver disease patients, male(14.1 %) was significantly higher than that(6.2%) in female. The positive rate of anti-HCV was significantly increased with age in liver disease patients(P<0.05), but in blood donors was not significantly. Anti-HCV was detected in 48.9 %(23/47) of hepatoma, 9.3 %(17/183) of liver cirrhosis, 8.4 %(28/333) of other chronic hepatitis. Relative risk for HBsAg was 6.98(95 % CI:4.11-11.86) in hepatoma(P<0.05). 3.60(95 % CI:2.86-4.53) in liver cirrhosis, 2.56(95 % CI: 2.10-2.88) in other chronic hepatitis. For anti-HCV, the relative risk in hepatoma was 13.45(95 % CI:8.91-20.32), in liver cirrhosis was 2.54(95 % CI:1.72-3.76), in other chronic hepatitis was 1.89(95 % CI: 1.44-2.49). These findings provide strong evidence that HCV infection is significantly correlated with hepatoma, and may even playa more important role than the hepatitis B virus.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼